PharmaFrontiers Names HTC Head Paul Frison To Board

October 19, 2005 |

1 min read

Cell therapy developer PharmaFrontiers Corporation (OTC BB:PFTR.OB - News) has elected Paul M. Frison, president and CEO of the Houston Technology Center (HTC), to the company's Board of Directors.

People

MORE ON THIS TOPIC

Various white pills and capsules forming a map of the world, illustrating humanity's increasing dependency on medication manufacturing.

Obesity

Lilly Prepares $1B+ Orforglipron Stock Ahead of Approval as Novo Brings Wegovy Pill Overseas

February 13, 2026

·

2 min read

·

Tristan Manalac

3D illustration of a fatty liver

Earnings

All Eyes on Vertex’s Kidney Franchise, as Painkiller Journavx Tops Half a Million Scripts

February 13, 2026

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Ultragenyx Downsizes By 10% After Bone Drug’s Phase 3 Fail

February 13, 2026

·

54 min read

·

BioSpace Editorial Staff

Contemporary artwork. Businessman jumping over bear trap with briefcase and documents. Concept of business risk, hidden financial dangers, legal pitfalls, investment fraud and consumer protection.

Vaccines

Flu Vaccine Rejection Imperils Moderna’s Breakeven Plans

February 12, 2026

·

4 min read

·

Dan Samorodnitsky